NCT00026780View on ClinicalTrials.gov

Eligibility Screening for a NCI Pediatric Oncology Branch Research Study

CompletedOBSERVATIONAL
Enrollment

1,720

Participants

Timeline

Start Date

September 24, 2001

Primary Completion Date

October 7, 2020

Study Completion Date

October 7, 2020

Conditions
Ewing SarcomaOsteosarcomaNeuroblastomaAcute Lymphoblastic LeukemiaNeurofibromatosis Type 1
Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00026780 - Eligibility Screening for a NCI Pediatric Oncology Branch Research Study | Biotech Hunter | Biotech Hunter